Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.
- NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_assertion description "[Conversely, inhibition of Src family tyrosine kinases by the pyrazolopyrimidine PP2, as in kinase-inactive Hck mutants, significantly reduces IL-6-triggered activation of extracellular signal-regulated kinase and AKT-1, leading to significant reduction of multiple myeloma cell proliferation and survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.
- NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_assertion evidence source_evidence_literature NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.
- NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_assertion SIO_000772 15010462 NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.
- NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_assertion wasDerivedFrom befree-20150227 NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.
- NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_assertion wasGeneratedBy ECO_0000203 NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP232139.RAJJnbSDVm4KUj-vLS3-SkqtI2rf3AMG2gSDlsgRGlYW0130_provenance.